High-Value Epilepsy Care in the United States: Predictors of Increased Costs and Complications from the National Inpatient Sample Database 2016-2019

被引:1
|
作者
Singh, Rohin [1 ]
Zamanian, Cameron [1 ]
Bcharah, George [2 ]
Stonnington, Henry [2 ]
George, Derek D. [1 ]
Bhandarkar, Archis R. [3 ]
Shahrestani, Shane [4 ]
Brown, Nolan [1 ]
Abraham, Mickey E. [5 ]
Mammis, Antonios [6 ]
Bydon, Mohamad [3 ]
Gonda, David [5 ]
机构
[1] Univ Rochester, Dept Neurosurg, Rochester, NY 14627 USA
[2] Mayo Clin, Dept Neurosurg, Scottsdale, AZ USA
[3] Mayo Clin, Dept Neurosurg, Rochester, MN USA
[4] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA USA
[5] Univ Calif San Diego, Dept Neurosurg, San Diego, CA USA
[6] NYU, Departmernt Neurosurg, New York, NY USA
关键词
Epilepsy; High value care; LITT; Resection; TEMPORAL-LOBE; SURGERY; MORTALITY; LOBECTOMY;
D O I
10.1016/j.wneu.2024.03.061
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: For patients with medically refractory epilepsy, newer minimally invasive techniques such as laser interstitial thermal therapy (LITT) have been developed in recent years. This study aims to characterize trends in the utilization of surgical resection versus LITT to treat medically refractory epilepsy, characterize complications, and understand the cost of this innovative technique to the public. METHODS: The National Inpatient Sample database was queried from 2016 to 2019 for all patients admitted with a diagnosis of medically refractory epilepsy. Patient demographics, hospital length of stay, complications, and costs were tabulated for all patients who underwent LITT or surgical resection within these cohorts. RESULTS: A total of 6019 patients were included, 223- nderwent LITT procedures, while 5796 underwent resection. Significant predictors of increased patient charges for both cohorts included diabetes (odds ratio: 1.7, confidence interval [CI]: 1.44-2.19), infection (odds ratio: 5.12, CI 2.739.58), and hemorrhage (odds ratio: 2.95, CI 2.04-4.12). Procedures performed at nonteaching hospitals had 1.54 greater odds (CI 1.02-2.33) of resulting in a complication compared to teaching hospitals. Insurance status did significantly differ ( P = 0.001) between those receiving LITT (23.3% Medicare; 25.6% Medicaid; 44.4% private insurance; 6.7 Other) and those undergoing resection (35.3% Medicare; 22.5% Medicaid; 34.7% private Insurance; 7.5% other). When adjusting for patient demographics, LITT patients had shorter length of stay (2.3 vs. 8.9 days, P < 0.001), lower complication rate (1.9% vs. 3.1%, P = 0.385), and lower mean hospital ($139,412.79 vs. $233,120.99, P < 0.001) and patient ($55,394.34 vs. $37,756.66, P < 0.001) costs. CONCLUSIONS: The present study highlights LITT 's advantages through its association with lower costs and shorter length of stay. The present study also highlights the associated predictors of LITT versus resection, such as that most LITT cases happen at academic centers for patients with private insurance. As the adoption of LITT continues, more data will become available to further understand these issues.
引用
收藏
页码:E1230 / E1243
页数:14
相关论文
共 50 条
  • [1] Outcomes of the First Episode of STEMI in Rheumatoid Arthritis from the National Inpatient Sample Database 2016-2019
    Suwal, Amar
    Shrestha, Biraj
    Oke, Ibiyemi
    Donato, Anthony
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3899 - 3901
  • [2] Sex Differences in Atrial Fibrillation Ablation Outcomes From the National Inpatient Sample Database 2016-2019
    Shrestha, Biraj
    Fraga, Julian Diaz
    Poudel, Bidhya
    Donato, Anthony
    CIRCULATION, 2022, 146
  • [3] Contemporary Trends of Subcutaneous Implantable Cardioverter Defibrillator Utilization in the United States: Insights From the National Inpatient Sample 2016-2019
    Shatla, Islam
    El Iskandarani, Mahmoud
    Kennedy, Kevin
    Wimmer, Alan P.
    CIRCULATION, 2022, 146
  • [4] Outcomes of the First Episode of STEMI in Rheumatoid Arthritis Patients from the National Inpatient Sample Database, 2016-2019
    Suwal, Amar
    Shrestha, Biraj
    Setyono, Devy
    Poudel, Bidhya
    Donato, Anthony
    CURRENT PROBLEMS IN CARDIOLOGY, 2022, 47 (10)
  • [5] Insights From the National Inpatient Sample (2016-2019) on Laryngeal Cancer Incidence and Trends
    Albazee, Ebraheem
    Alharran, Abdullah M.
    Alzayed, Mooza M.
    Alharran, Yousef M.
    Alyaqout, Fajer B.
    Almutairi, Ahmed
    Abu-Zaid, Ahmed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [6] HEALTHCARE DISPARITIES IN PATIENTS WITH CRITICAL LIMB THREATENING ISCHEMIA: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE DATABASE 2016-2019
    Torres, Christian
    Ujueta, Francisco
    Rogers, Everett
    Lozier, Matthew R.
    Torres-Ortiz, Hernando
    Ghazzal, Amre
    Beohar, Nirat
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2108 - 2108
  • [7] Sex differences in atrial fibrillation ablation in-hospital outcomes from the National Inpatient Sample database 2016-2019
    Shrestha, Biraj
    Fraga, Julian Diaz
    Poudel, Bidhya
    Donato, Anthony
    JOURNAL OF ARRHYTHMIA, 2023, 39 (02) : 149 - 158
  • [8] COMPLICATIONS ASSOCIATED WITH LEAD EXTRACTION IN DEVICE RELATED INFECTIONS: ANALYSIS OF THE NATIONAL INPATIENT SAMPLE 2016-2019
    Kodali, Mouna
    Atluri, Ramtej
    Shoura, Sami
    Vardar, Ufuk
    Vallabhaneni, Meghana
    Yalamanchili, Sreeram
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 268 - 268
  • [9] IN HOSPITAL OUTCOMES OF IRON DEFICIENCY ANEMIA IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS IN UNITED STATES: A NATIONAL INPATIENT SAMPLE ANALYSIS OF 2016-2019
    Faisaluddin, Mohammed
    Ahmed, Asmaa
    Osama, Muhammad
    Patel, Harsh
    Thakkar, Samarthkumar
    Dey, Amit
    Dani, Sourbha S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 748 - 748
  • [10] Utilization of inpatient palliative care services among adolescents and young adults with cancer: Evidence from National Inpatient Sample 2016-2019
    Yadav, Sandhya
    Turner, Kea
    Xie, Zhigang
    Chen, Guanming
    Islam, Jessica Y. Y.
    Suk, Ryan
    Hong, Young-Rock
    PALLIATIVE & SUPPORTIVE CARE, 2023,